More than ever before, in this crucially important year, the EAPM Conference will allow for a bridge to national representatives is order to further build on the developments that the Alliance has helped to architect in various policy ;

It is the ideal one-stop shop, as stakeholders from every discipline and every Member State come together to forge the way ahead.

So don’tmiss thisopportunity to join large numbers of industry professionals, government regulators, patients, academia, researchers, healthcare journalists and more into drivinginsights into action.

Key topics to be discussed in Brussels will include: 

- Personalised Medicine and the Innovation Agenda: An Integrated Approach

 - Technology Developments 

 - Hematology - Personalised Treatments and Personalised Prevention 

 - Pharmaceutical/Diagnostics - The Regulatory Framework (Part I)

 - Pharmaceutical/Diagnostics - The Regulatory Framework (Part II)

 - Political Will and Institutional Support

Of course, the implications of Britain’s departure will also be on the agenda, as will the reorganisation of the European Parliament after the UK leaves, plus what can be expected after the elections with its implications for the new Commission - not least the identity of its President as Jean-Claude Juncker steps down.

Therefore, if you are a stakeholder in personalised medicine in particular, or the advancement of healthcare in general, this is the ideal forum for sharing your views and expertise while absorbing that of others.

We hope to see you in Brussels in April!